Please provide your email address to receive an email when new articles are posted on . Removing the race-specific coefficient from the equation that determines eGFR results in a “small but ...

As eGFR decreased, risks for 30-day hospital readmission or death increased for patients with chronic kidney disease, according to study data published in Clinical Journal of the American Society of ...

A randomized, controlled, nonblinded trial found that nutritional treatment with supportive education could help improve renal function in patients with chronic kidney disease (CKD). A study published ...

An arsenal of highly effective medications now represent pillars in the prevention of chronic kidney disease (CKD) progression, yet with the drugs under-utilized among patients who need them the most, ...

Chronic kidney disease (CKD) refers to gradual kidney damage that reduces the kidneys’ ability to filter blood. CKD progresses through stages 1 to 5. Stage 4 CKD is the final stage before complete ...

Dr Jeffrey Feldman discusses finerenone trial data and the role that it and SGLT2 inhibitors have played in patients with CKD. Ryan Haumschild, PharmD, MS, MBA: Dr Feldman, hearing these positive ...

ProKidney Corp. announced positive topline results from its Phase 2 REGEN-007 trial of rilparencel in patients with chronic kidney disease (CKD) and diabetes, indicating significant improvement in ...

Meanwhile, as researchers struggle to arrive at normalvalues, medical organizations feel compelled to promulgate guidelines as a wayto improve patient care and to ensure that medical treatments are ...

The estimated glomerular filtration rate (eGFR) is a blood test to assess kidney function. The formula for calculating eGFR takes the patient’s body size, age, and sex into account to predict how well ...